IL186880A0 - Evolved interferon alpha polypeptides - Google Patents

Evolved interferon alpha polypeptides

Info

Publication number
IL186880A0
IL186880A0 IL186880A IL18688007A IL186880A0 IL 186880 A0 IL186880 A0 IL 186880A0 IL 186880 A IL186880 A IL 186880A IL 18688007 A IL18688007 A IL 18688007A IL 186880 A0 IL186880 A0 IL 186880A0
Authority
IL
Israel
Prior art keywords
interferon alpha
alpha polypeptides
evolved interferon
evolved
polypeptides
Prior art date
Application number
IL186880A
Other languages
English (en)
Original Assignee
Maxygen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maxygen Inc filed Critical Maxygen Inc
Publication of IL186880A0 publication Critical patent/IL186880A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL186880A 2005-05-18 2007-10-24 Evolved interferon alpha polypeptides IL186880A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68276905P 2005-05-18 2005-05-18
PCT/US2006/019088 WO2007044083A2 (en) 2005-05-18 2006-05-17 Evolved interferon-alpha polypeptides

Publications (1)

Publication Number Publication Date
IL186880A0 true IL186880A0 (en) 2008-02-09

Family

ID=37943260

Family Applications (1)

Application Number Title Priority Date Filing Date
IL186880A IL186880A0 (en) 2005-05-18 2007-10-24 Evolved interferon alpha polypeptides

Country Status (11)

Country Link
US (1) US7619067B2 (https=)
EP (1) EP1888633A4 (https=)
JP (1) JP2008545393A (https=)
KR (1) KR20080019619A (https=)
CN (1) CN101501068A (https=)
AU (1) AU2006299901A1 (https=)
BR (1) BRPI0609809A2 (https=)
CA (1) CA2607651A1 (https=)
IL (1) IL186880A0 (https=)
MX (1) MX2007014524A (https=)
WO (1) WO2007044083A2 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000040715A2 (en) 1999-01-05 2000-07-13 Trustees Of Boston University Improved nucleic acid cloning
US7435562B2 (en) 2000-07-21 2008-10-14 Modular Genetics, Inc. Modular vector systems
EP1817413B1 (en) 2004-11-11 2012-01-04 Modular Genetics, Inc. Oligonucleotide ladder assembly and system for generating molecular diversity
US7625555B2 (en) 2007-06-18 2009-12-01 Novagen Holding Corporation Recombinant human interferon-like proteins
CA2698173C (en) * 2007-09-04 2015-02-03 Biosteed Gene Expression Tech. Co., Ltd. Interferon alpha 2b modified by polyethylene glycol, the preparation and use thereof
AT506535B1 (de) * 2008-02-22 2010-04-15 Affiris Forschungs & Entwicklungs Gmbh Vaccine enthaltend alpha-synuclein-mimotope auf basis von peptiden
CA2721093A1 (en) 2008-04-11 2009-10-15 Merrimack Pharmaceuticals, Inc. Human serum albumin linkers and conjugates thereof
CA2721870C (en) 2008-04-21 2020-12-22 Tissue Regeneration Therapeutics, Inc. Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents
WO2010142017A1 (en) 2009-06-09 2010-12-16 Defyrus, Inc . Administration of interferon for prophylaxis against or treatment of pathogenic infection
CN101921330B (zh) * 2010-06-02 2013-07-17 北京三元基因工程有限公司 重组人干扰素α1b突变体及其制备方法
ES2800426T3 (es) 2012-03-03 2020-12-30 Immungene Inc Moléculas de fusión anticuerpos-mutante de interferón modificadas
CA2998456A1 (en) 2015-09-15 2017-03-23 Alfacyte Ltd Compositions and methods relating to the treatment of diseases
CN108733975B (zh) * 2018-03-29 2021-09-07 深圳裕策生物科技有限公司 基于二代测序的肿瘤克隆变异检测方法、装置和存储介质
CN111499718B (zh) * 2019-01-30 2022-06-14 复旦大学 人α干扰素受体结合相关位点突变体及其用途
CN110272480B (zh) * 2019-06-13 2022-07-22 江苏科技大学 鸭α干扰素及其突变体、制备方法和应用
HRP20240949T1 (hr) * 2020-03-16 2024-10-25 Ilc Therapeutics Ltd Hibridni interferoni za liječenje virusnih infekcija
EP3901168A1 (en) * 2020-04-21 2021-10-27 Universität Duisburg-Essen Interferon alpha 2 variants and uses thereof

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6610830B1 (en) 1980-07-01 2003-08-26 Hoffman-La Roche Inc. Microbial production of mature human leukocyte interferons
ES8302778A1 (es) 1980-11-10 1983-02-01 Genentech Inc Un procedimiento para producir un polipeptido antiviral.
US4414150A (en) 1980-11-10 1983-11-08 Genentech, Inc. Hybrid human leukocyte interferons
WO1983002461A1 (en) 1982-01-19 1983-07-21 Cetus Corp Multiclass hybrid interferons
US6936694B1 (en) 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
EP0205404B1 (en) 1985-06-11 1992-07-15 Ciba-Geigy Ag Hybrid interferons
US5372808A (en) 1990-10-17 1994-12-13 Amgen Inc. Methods and compositions for the treatment of diseases with consensus interferon while reducing side effect
AU660633B2 (en) 1990-10-17 1995-07-06 Amgen, Inc. Methods and compositions for the treatment of cell proliferation disorders
US5595732A (en) 1991-03-25 1997-01-21 Hoffmann-La Roche Inc. Polyethylene-protein conjugates
US5382657A (en) 1992-08-26 1995-01-17 Hoffmann-La Roche Inc. Peg-interferon conjugates
US5780021A (en) * 1993-03-05 1998-07-14 Georgetown University Method for treating type 1 diabetes using α-interferon and/or β-i
US5574138A (en) * 1993-03-08 1996-11-12 Immunex Corporation Epithelium-derived T-cell factor
US6335160B1 (en) 1995-02-17 2002-01-01 Maxygen, Inc. Methods and compositions for polypeptide engineering
AU1854695A (en) 1994-03-07 1995-09-25 Imperial College Of Science, Technology And Medicine The use of interferon subtypes in the preparation of medicaments to treat viral infections
US5824784A (en) 1994-10-12 1998-10-20 Amgen Inc. N-terminally chemically modified protein compositions and methods
TW517067B (en) 1996-05-31 2003-01-11 Hoffmann La Roche Interferon conjugates
ATE375363T1 (de) 1997-07-14 2007-10-15 Bolder Biotechnology Inc Derivate des wachstumshormons und verwandte proteine
BR122013003013B8 (pt) 1999-01-14 2021-07-06 Bolder Biotechnology Inc proteína isolada monopeguilada do hormônio do crescimento e método para sua obtenção
AU3725600A (en) 1999-03-02 2000-09-21 Maxygen, Inc. Surrogate orphan ligands for orphan receptors
ATE369384T1 (de) 1999-05-19 2007-08-15 Emd Lexigen Res Ct Corp Expression und export von interferon-alpha proteinen als fc fusionsproteine
US20040002474A1 (en) 1999-10-07 2004-01-01 Maxygen Inc. IFN-alpha homologues
WO2001025438A2 (en) 1999-10-07 2001-04-12 Maxygen, Inc. Ifn-alpha homologues
IL152804A0 (en) 2000-05-16 2003-06-24 Bolder Biotechnology Inc Methods for refolding proteins containing free cysteine residues
WO2002044197A2 (en) 2000-12-01 2002-06-06 Fish Eleanor N Cytokine receptor binding peptides
KR100459105B1 (ko) 2001-02-15 2004-12-03 선바이오(주) 변형된 인터페론-알파 2ａ 및 2ｂ, 그리고 이들과 ＰＥＧ유도체와의 배합체
WO2004045648A1 (en) 2002-11-15 2004-06-03 F. Hoffmann-La Roche Ag Positional isomers of peg ifn alpha 2a
EP1565205A4 (en) 2002-11-18 2006-07-05 Maxygen Inc Interferon-alpha polypeptides and conjugates
AU2005245918A1 (en) 2004-05-19 2005-12-01 F. Hoffmann-La Roche Ag Interferon-alpha polypeptides and conjugates

Also Published As

Publication number Publication date
WO2007044083A3 (en) 2009-04-16
CA2607651A1 (en) 2007-04-19
CN101501068A (zh) 2009-08-05
EP1888633A4 (en) 2010-01-27
KR20080019619A (ko) 2008-03-04
EP1888633A2 (en) 2008-02-20
JP2008545393A (ja) 2008-12-18
BRPI0609809A2 (pt) 2011-10-11
US20080226597A1 (en) 2008-09-18
MX2007014524A (es) 2008-02-07
AU2006299901A1 (en) 2007-04-19
US7619067B2 (en) 2009-11-17
WO2007044083A2 (en) 2007-04-19

Similar Documents

Publication Publication Date Title
IL186880A0 (en) Evolved interferon alpha polypeptides
GB0524788D0 (en) Polypeptides
IL184428A0 (en) Peptides with neuropeptide-2-receptor
ZA200700895B (en) Polypeptide
GB0508863D0 (en) Peptide
GB0621513D0 (en) Novel polypeptides and uses thereof
EP1868636A4 (en) USE OF RECOMBINANT SUPERCOMPOSE INTERFERONS
GB0505975D0 (en) Novel use of peptide
ZA200610812B (en) Keratin-binding polypeptides
GB0423974D0 (en) Proteins
AP2008004512A0 (en) Bacteriocion inducer peptides
GB0505949D0 (en) Polypeptides
GB0526019D0 (en) Peptides
IL170762A0 (en) Improved alumina-based ceramic objects
GB0415196D0 (en) Polypeptide
GB0516527D0 (en) Peptides
GB0402904D0 (en) Polypeptide
GB0516571D0 (en) Novel polypeptides and uses thereof
GB2401581B (en) Ceramic labelling
GB0504769D0 (en) Polypeptides
GB0423002D0 (en) Proteins
GB0511861D0 (en) Proteins
GB0400606D0 (en) Polypeptide
GB0400605D0 (en) Polypeptide
GB0522113D0 (en) vWFA-domain containing proteins